Hysterectomy Clinical Trials

Clinical trials related to Hysterectomy Procedure

HYbrid RObotic Surgery in Gynecology (HYROS-GYN)

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this clinical investigation is to evaluate the safety and performance of ROB and its corresponding ElectroSurgical Endoscopic instruments and Non-ElectroSurgical Endoscopic instruments (ESE and NESE instruments respectively) and accessories in patients with the indication of robot assisted laparoscopic Hysterectomy, Hysterectomy and Salpingectomy or Hysterectomy and Salpingectomy and Oophorectomy and when it applies Lysis of Adhesions, Lymphadenectomy and Sentinel lymph node biopsy (SLNB). HYROS-GYN is a confirmatory study in which the hypothesis of the primary endpoint is that the ESE/NESE instruments perform as intended when controlled by ROB which operates exclusively under surgeon's orders. It will include the data collected up to 30 days post-surgery.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:

• \- Subjects with a gynecological indication for a laparoscopic total hysterectomy, with or without salpingectomy and/or oophorectomy (i.e., removal of one or both fallopian tubes and/or ovaries).

• \- Subjects that additionally to the hysterectomy procedure may require sentinel lymph node biopsy (SLN) and/or pelvic lymphadenectomy (LND) according to investigator criteria.

• \- Ability and willingness to comply with all study requirements to be evaluated for each study visit

Locations
Other Locations
Spain
Hospital Universitari Vall d'Hebron
RECRUITING
Barcelona
Hospital Comarcal d'Inca
NOT_YET_RECRUITING
Inca
Contact Information
Primary
Mario P Ferradosa, General Manager RSS
mario.ferradosa@robsurgical.com
+34 930130883
Time Frame
Start Date: 2026-10
Estimated Completion Date: 2027-01
Participants
Target number of participants: 9
Treatments
Experimental: Patients surgically treated with ROB Bitrack System and ESE/ NESE instruments and accessories
Related Therapeutic Areas
Sponsors
Leads: Rob Surgical Systems S.L.

This content was sourced from clinicaltrials.gov